Dr Kevin Oliver Maguigad Mercado, PHARMD | |
1619 Ambler Ave, Abilene, TX 79601-2235 | |
(325) 672-4100 | |
Not Available |
Full Name | Dr Kevin Oliver Maguigad Mercado |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1619 Ambler Ave, Abilene, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528578283 | NPI | - | NPPES |
61196 | Other | TX | TEXAS REGISTERED PHARMACIST |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 61196 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kevin Oliver Maguigad Mercado, PHARMD 1619 Ambler Ave, Abilene, TX 79601-2235 Ph: () - | Dr Kevin Oliver Maguigad Mercado, PHARMD 1619 Ambler Ave, Abilene, TX 79601-2235 Ph: (325) 672-4100 |
News Archive
The NFL and National Dairy Council (NDC) today launch Fuel Up to Play 60, a new initiative aimed at tackling childhood obesity by giving youth a voice in changing the school nutrition and physical activity environment. The program will reach 36 million youth in 60,000 elementary, middle and high schools during the 2009/2010 school year.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to SolirisĀ® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
To promote early detection and an overall healthy lifestyle that can help prevent the onset of diabetes, Sam's Club Pharmacy will host free health screenings Saturday, Sept. 14, from 11 a.m. to 3 p.m.
A team from the George Washington University Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
› Verified 1 days ago
Dr. Molly Graham Minze, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Pine St, Abilene, TX 79601 Phone: 325-676-7948 | |
Victoria Nguyen, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1005 N Judge Ely Blvd, Abilene, TX 79601 Phone: 325-672-1842 | |
Dr. Troy Walters, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 991 N Willis St, Abilene, TX 79603 Phone: 325-676-2392 | |
Dr. Rachel Marie Moore, PHARMD, BCACP,BC-ADM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5302 Buffalo Gap Rd, Abilene, TX 79606 Phone: 325-670-4545 | |
Toni Simmons Little, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4450 Buffalo Gap Rd, Abilene, TX 79606 Phone: 325-695-4690 Fax: 325-695-5820 | |
Catherine Caroline Wright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Pine St Rm 2801, Abilene, TX 79601 Phone: 325-670-3068 | |
Mr. David Kent Johnson, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Maple St, Abilene, TX 79602 Phone: 325-795-3596 Fax: 325-795-3203 |